Abbott's HUMIRA(R) (adalimumab) FDA-Approved For Moderate to Severe Chronic Plaque Psoriasis
Title: Abbott's HUMIRA(R) (adalimumab) FDA-Approved For Moderate to Severe Chronic Plaque Psoriasis
PermaLink: http://www.straightfromthedoc.com/50226711/abbotts_humirar_adalimumab_fdaapproved_for_moderate_to_severe_chronic_plaque_psoriasis.php
Filed in archive FDA Approvals , Psoriasis & Skin Diseases , Treatment by Gloria Gamat on January 21, 2008
The US FDA has recently approved the marketing of Abbott's HUMIRA(R) (adalimumab) as a treatment for adult patients with moderate to severe chronic plaque psoriasis. Plaque psoriasis is an...
